Suppr超能文献

大鼠抗胸腺细胞球蛋白诱导心脏同种异体移植耐受诱导期的特征

Characteristics of the induction phase of antithymocyte-globulin-induced heart allograft tolerance in the rat.

作者信息

Olausson M, Mjörnstedt L, Wramner L, Lindholm L, Söderström T, Brynger H

机构信息

Department of Surgery I, University of Göteborg, Sweden.

出版信息

Int Arch Allergy Appl Immunol. 1988;86(2):131-8. doi: 10.1159/000234562.

Abstract

Transplantation tolerance was induced in 50% of Wky rats treated with antithymocyte globulin (ATG) 2 days prior to transplantation of a PVG/c heart. The induction period immediately following ATG treatment and transplantation was characterized by instability, with 50% of the allografts being lost in rejection within 30 days after transplantation. Second syngeneic transplantation to ATG-treated recipients 5 days after the first transplantation facilitated tolerance induction and permanent acceptance of both transplants. Thirty days after ATG treatment and the primary transplantation, 50% of second syngeneic allografts were accepted. During the early period after transplantation a continuous antigen presence together with ATG was necessary. Graft removal and absence of the transplant for 3 days, close to ATG administration, resulted in rejection of a second PVG/c transplant. Furthermore, the induction phase could easily be manipulated by the addition of sensitized or tolerized spleen cells to the recipient, causing allograft rejection or tolerance, respectively. Sixty days after ATG treatment and transplantation, a longer period between graft removal and retransplantation was required to break tolerance. Injection of sensitized spleen cells at this time did not affect graft survival, indicating an increased stability of the unresponsive state 60 days after ATG treatment and transplantation.

摘要

在将PVG/c心脏移植给Wky大鼠前2天用抗胸腺细胞球蛋白(ATG)处理,50%的Wky大鼠诱导出移植耐受。ATG处理及移植后的诱导期具有不稳定性,50%的同种异体移植物在移植后30天内因排斥反应而丢失。首次移植5天后对接受ATG处理的受体进行第二次同基因移植,有助于诱导耐受并永久接受两次移植。ATG处理及初次移植30天后,50%的第二次同基因同种异体移植物被接受。在移植后的早期,持续存在抗原并联合使用ATG是必要的。在接近给予ATG时去除移植物且移植缺失3天,会导致第二次PVG/c移植被排斥。此外,通过向受体添加致敏或耐受的脾细胞,可分别轻易地操纵诱导期,导致同种异体移植排斥或耐受。ATG处理及移植60天后,需要在移植物去除和再次移植之间有更长的间隔时间来打破耐受。此时注射致敏脾细胞不影响移植物存活,表明ATG处理及移植60天后无反应状态的稳定性增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验